![Paul Atkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul J.
Atkins was the founder of Oriel Therapeutics, Inc., where he served as Chief Executive Officer from 2002 to 2009.
He is currently the Executive Chairman of Nob Hill Therapeutics, Inc. since 2021 and is also a member of the Advisory Board at VIC Technology Venture Development LLC.
Postes actifs de Paul Atkins
| Sociétés | Poste | Début |
|---|---|---|
Nob Hill Therapeutics, Inc.
 Nob Hill Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops dry powder nebulizers for the treatment of severe respiratory diseases | Président | 20/04/2021 |
VIC Technology Venture Development LLC
 VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology invests in companies located in the United States. The firm focuses on life science and technology. It participates in seed and early stage transactions with an investment size ranging of USD 0.2 - 0.5 million and it also makes follow-on investments. | Consultant / Advisor | - |
Anciens postes connus de Paul Atkins
| Sociétés | Poste | Fin |
|---|---|---|
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Oriel Therapeutics, Inc.
Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Health Technology |
VIC Technology Venture Development LLC
VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology invests in companies located in the United States. The firm focuses on life science and technology. It participates in seed and early stage transactions with an investment size ranging of USD 0.2 - 0.5 million and it also makes follow-on investments. | Finance |
Nob Hill Therapeutics, Inc.
Nob Hill Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops dry powder nebulizers for the treatment of severe respiratory diseases | Health Technology |
